Increased Risk of Cardiac Ischaemia in a Pan-European CohortReport on cumulative incidence of symptomatic cardiac ischaemia and its risk factors among European 5-year childhood cancer survivors.

The article concludes that by age 60 years, 1 in 18 CCS will develop a severe, life-threatening or fatal cardiac ischaemia, especially in lymphoma survivors and CCS treated with radiotherapy and chemotherapy increases the risk significantly.